<DOC>
	<DOCNO>NCT01798784</DOCNO>
	<brief_summary>In 4-arm , Randomized Control Trial among member CVS Caremark Penn Medicine Patients suboptimal cholesterol control high risk CVD , study investigator propose test effectiveness different behavioral economic technique induce habit formation adherence statin use sustain reduction LDL cholesterol financial incentive discontinue . Primary outcome change LDL enrollment 12 month ( 6 month cessation financial incentive ) .</brief_summary>
	<brief_title>Habit Formation Adherence Statin Use LDL Reduction</brief_title>
	<detailed_description />
	<criteria>Individuals high risk cardiac event , specifically one following : Individuals clinical CVD ( define diagnosis myocardial infarction , stroke , peripheral vascular disease ) LDL great equal 100 mg/dl ; Individuals Diabetes ( age 4075 ) LDL great equal 100 mg/dl ; Individuals without clinical CVD diabetes LDL great equal 100 mg/dl estimate 10year CVD risk 7.5 % ; Individuals without clinical CVD diabetes LDL cholesterol great equal 190 mg/dl A prescription fill statin medication within last 12 month ( derive pharmacy record ) ; Medication Possession Ratio ( MPR ) less equal 80 % A score 0 8item Morisky Medication Adherence Questionnaire complete enrollment Less 18 year old Contraindication statin use suffer side effect statin , myopathy Will give consent History active progressive liver disease abnormal liver function test baseline screen Currently participate another clinical trial relate aim Comorbidities likely lead death within shortperiod</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>